Viewing Study NCT06364956


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-06-26 @ 5:36 AM
Study NCT ID: NCT06364956
Status: RECRUITING
Last Update Posted: 2025-08-11
First Post: 2024-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tislelizumab View
None Palbociclib View
None neoadjuvant View
None bladder cancer View